메뉴 건너뛰기




Volumn 99, Issue SUPPL. 1, 2007, Pages 19-22

The current status of intermittent androgen deprivation (IAD) therapy for prostate cancer: Putting IAD under the spotlight

Author keywords

Intermittent androgen deprivation therapy; Prostate cancer

Indexed keywords

ANTIANDROGEN; BICALUTAMIDE; GONADORELIN AGONIST; PROSTATE SPECIFIC ANTIGEN;

EID: 33845645525     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.06596.x     Document Type: Conference Paper
Times cited : (45)

References (12)
  • 2
    • 0027416692 scopus 로고
    • Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen
    • Akakura K, Bruchovsky N, Goldenberg SL, Rennie PS, Buckley AR, Sullivan LD. Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen. Cancer 1993; 71: 2782-90
    • (1993) Cancer , vol.71 , pp. 2782-2790
    • Akakura, K.1    Bruchovsky, N.2    Goldenberg, S.L.3    Rennie, P.S.4    Buckley, A.R.5    Sullivan, L.D.6
  • 3
    • 0028245279 scopus 로고
    • Effect of tumour progression on the androgenic regulation of the androgen receptor, TRPM-2 and YPT1 genes in the Shionogi carcinoma
    • Rennie PS, Bruchovsky N, Akakura K et al. Effect of tumour progression on the androgenic regulation of the androgen receptor, TRPM-2 and YPT1 genes in the Shionogi carcinoma. J Steroid Biochem Mol Biol 1994; 50: 31-40
    • (1994) J Steroid Biochem Mol Biol , vol.50 , pp. 31-40
    • Rennie, P.S.1    Bruchovsky, N.2    Akakura, K.3
  • 4
    • 0027239899 scopus 로고
    • Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol
    • Bruchovsky N, Goldenberg SL, Akakura K, Rennie PS. Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol. Cancer 1993; 72: 1685-91
    • (1993) Cancer , vol.72 , pp. 1685-1691
    • Bruchovsky, N.1    Goldenberg, S.L.2    Akakura, K.3    Rennie, P.S.4
  • 5
    • 0029656221 scopus 로고    scopus 로고
    • Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer
    • Gleave ME, Goldenberg SL, Jones EC, Bruchovsky N, Sullivan LD. Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer. J Urol 1996; 155: 213-9
    • (1996) J Urol , vol.155 , pp. 213-219
    • Gleave, M.E.1    Goldenberg, S.L.2    Jones, E.C.3    Bruchovsky, N.4    Sullivan, L.D.5
  • 6
    • 33645341444 scopus 로고    scopus 로고
    • Enhancement of intermittent androgen ablation by 'off-cycle' maintenance with finasteride in LNCaP prostate cancer xenograft model
    • Eggener SE, Stern JA, Jain PM et al. Enhancement of intermittent androgen ablation by 'off-cycle' maintenance with finasteride in LNCaP prostate cancer xenograft model. Prostate 2006; 66: 495-502
    • (2006) Prostate , vol.66 , pp. 495-502
    • Eggener, S.E.1    Stern, J.A.2    Jain, P.M.3
  • 7
    • 33845650801 scopus 로고    scopus 로고
    • International study of the intermittent treatment of cancer of the prostate
    • Proceedings of the International Study of Intermittent Therapy for Cancer of the Prostate (ISICAP) Meeting, Vancouver, Canada, March 2006. abstract 88
    • Shaw GL. International study of the intermittent treatment of cancer of the prostate. Proceedings of the International Study of Intermittent Therapy for Cancer of the Prostate (ISICAP) Meeting, Vancouver, Canada, March 2006. Ann Oncol 2005; 16 (Suppl. 2): abstract 88
    • (2005) Ann Oncol , vol.16 , Issue.SUPPL. 2
    • Shaw, G.L.1
  • 8
    • 0042914929 scopus 로고    scopus 로고
    • Intermittent androgen deprivation for locally advanced prostate cancer. Preliminary experience from an ongoing randomized controlled study of the South European urooncological group
    • Calais da Silva F, Bono A, Whelan P et al. Intermittent androgen deprivation for locally advanced prostate cancer. Preliminary experience from an ongoing randomized controlled study of the South European urooncological group. Oncology 2003; 65 (Suppl 1): 24-28
    • (2003) Oncology , vol.65 , Issue.SUPPL. 1 , pp. 24-28
    • Calais Da Silva, F.1    Bono, A.2    Whelan, P.3
  • 9
  • 10
    • 3442876782 scopus 로고    scopus 로고
    • Intermittent is as effective as continuous androgen deprivation in patients with PSA relapse after radical prostatectomy
    • abstract 1458
    • Tunn U, Kurek R, Keinle E et al. Intermittent is as effective as continuous androgen deprivation in patients with PSA relapse after radical prostatectomy. J Urol 2004; 171: 384, abstract 1458
    • (2004) J Urol , vol.171 , pp. 384
    • Tunn, U.1    Kurek, R.2    Keinle, E.3
  • 12
    • 24044440772 scopus 로고    scopus 로고
    • Long-term side-effects of intermittent androgen suppression therapy in prostate cancer: Results of a phase II study
    • Malone S, Perry G, Segal R, Dahrouge S, Crook J. Long-term side-effects of intermittent androgen suppression therapy in prostate cancer: results of a phase II study. BJU Int 2005; 96: 514-20
    • (2005) BJU Int , vol.96 , pp. 514-520
    • Malone, S.1    Perry, G.2    Segal, R.3    Dahrouge, S.4    Crook, J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.